75N93026F00001↗
PPD Development LP received this contract from National Institutes of Health Niaid, National Institutes of Health: $3.09M obligated so far for health r&d services; health care - other; applied research. It runs to 2026-12-14, or to 2028-12-14 if every option is exercised.
Key facts · data as of Oct 25, 2026
- Recipient
- PPD Development LP
- Awarding agency
- National Institutes of Health (Department of Health and Human Services)
- Contracting office
- National Institutes of Health Niaid (75N930)
- Obligated to date
- $3.09M
- Potential value
- $21.60M
- Ends
- 2026-12-14
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 25, 2026.
Cite this page: SpendQuery, Award 75N93026F00001, data as of Oct 25, 2026, https://spendquery.com/award?id=CONT_AWD_75N93026F00001_7529_75N93021D00035_7529
PPD Development LP: all federal awards · Department of Health and Human Services: spending · National Institutes of Health Niaid: what it buys · The follow-on: recompete brief
DAIDS MONITORING FOR 1 PHASE III STUDY: A5300B/I2003B (PHOENIX)
Up for re-bid: ends 2026-12-14. Recompete brief → · Pre-Clinical Models of Infectious Diseases ↗
What it is
- Product or service
- Health R&D Services; Health Care - Other; Applied Research (PSC AN42)
- Industry
- Research and Development in Biotechnology (Except Nanobiotechnology) (NAICS 541714)
- Contracting office
- National Institutes of Health Niaid (75N930)
- Competition
- Full and open competition
- Pricing
- Cost plus fixed fee
- How it was bought
- Single-award IDIQ · under 75N93021D00035
- Solicitation
- 75N93025R00010
- Where the work is
- New Hanover, NC · district NC-07
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
Every action
1 action since 2025-12-10. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2025-12-10 | 0 | $3.09M | DAIDS MONITORING FOR 1 PHASE III STUDY: A5300B/I2003B (PHOENIX) |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-25). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗